☽
Trending News
Medical misogyny leaves many women undiagnosed with iron deficiency due to biased reference ranges and normalized symptoms according to recent investigations.

Why medical misogyny leaves women dying of low iron

Abigail Rodwell was vomiting, struggling to breathe, and cramping in pain when paramedics carried her into the emergency department in 2016. The head nurse yelled that she would stop screaming or face accusations of being on drugs. Her hemoglobin measured 56 grams per liter, a level typical of traumatic blood loss, yet doctors had spent years telling the mother of two that her fatigue, headaches, and gastrointestinal symptoms stemmed from the stress of running a business, studying, and raising children.

Rodwell’s case appears among more than 50 accounts of severe iron deficiency or anemia collected in a 2025 Sydney Morning Herald investigation. Over 2,000 women responded to the newspaper’s call for stories of medical misogyny, describing how their symptoms were dismissed as normal or imagined. Iron deficiency impairs oxygen transport, immune function, and brain health, and untreated cases can progress to life-threatening anemia.

Reference ranges built on outdated assumptions

Many pathology providers in Australia long maintained separate ferritin thresholds for women and men. Laboratories set the lower limit of normal at 15 micrograms per liter for females while using 30 micrograms per liter for males. Professor Nada Hamad, a Sydney haematologist, called the split “insane” because a man with the same result would receive a diagnosis and treatment that a woman would be denied.

The Royal College of Pathologists of Australia updated national guidelines in 2021 to a single threshold of 30 micrograms per liter for adults. Several major providers, including Douglass Hanly Moir and NSW Health Pathology, have since aligned their ranges or announced plans to do so. Dr. Talat Uppal, an obstetrician and gynaecologist, noted that the lower female cutoff perpetuates gender-based inequity and delays care for a common, treatable condition.

Research indicates that between 25 and 50 percent of iron-deficient women are missed when the 15 micrograms per liter cutoff remains in use. A 2023 JAMA study of U.S. females aged 12 to 21 found iron deficiency prevalence reached 38.6 percent using a 25 micrograms per liter threshold, with the rate climbing further at higher cutoffs. These figures show how laboratory standards directly shape who receives recognition and intervention.

A person with styled blonde hair, wearing a white buckled restraint around their neck and across their upper chest, appearing distressed, set against a green geometric background.

Symptoms dismissed as ordinary female experience

Heavy menstrual bleeding affects roughly one in four women of reproductive age and ranks as the leading cause of iron deficiency. Many women in the Sydney Morning Herald accounts reported that clinicians labeled excessive bleeding as an untreatable fact of womanhood rather than a medical issue requiring investigation for polyps, fibroids, or clotting disorders.

Kate Burns, then 21, endured constant headaches, extreme fatigue, dizziness, and severe reflux for nearly two years before diagnosis. Multiple general practitioners attributed her symptoms to anxiety or exaggeration. Only after her father insisted on blood tests did results reveal ferritin at 6 micrograms per liter and confirm celiac disease, which had blocked iron absorption.

Even when oral iron supplements were prescribed, side effects such as nausea, constipation, and worsened reflux led many women to discontinue treatment without alternatives. Haematologist Dr. Lisa Clarke observed that patients with years of untreated deficiency often arrive in emergency departments severely anaemic because the healthcare system has failed to view non-anaemic iron deficiency in women as clinically significant.

Pregnancy and systemic gaps compound the harm

Pregnancy increases iron demand by approximately one gram across gestation. Estimates suggest up to 70 percent of women in the third trimester may be iron deficient. The U.S. Preventive Services Task Force has cited insufficient evidence to recommend routine screening for asymptomatic pregnant individuals, leaving decisions to individual providers who often test only after symptoms appear.

Angela Weyand, a pediatric hematologist at the University of Michigan, has documented how vague symptoms such as fatigue and brain fog are frequently attributed to pregnancy itself or to lack of sleep. A separate NHANES analysis of reproductive-age women found iron deficiency in 27.4 percent of nonpregnant participants and 75.5 percent of pregnant participants when inflammation-adjusted ferritin thresholds were applied.

A woman holding a book titled Miss Diagnosed, with a simple illustration of a uterus featuring a question mark on the cover.

Racial and socioeconomic disparities widen the impact. Non-Hispanic Black women showed nearly five times the rate of iron-deficiency anemia compared with non-Hispanic White women in recent U.S. data. These gaps persist after adjustment for income and education, reflecting differences in access to care and historical diagnostic standards that set lower anemia thresholds for Black women.

Financial and structural barriers limit effective treatment

Iron infusions replenish stores more rapidly than oral supplements and avoid gastrointestinal side effects, yet Medicare provides no rebate for the procedure in general practice. Patients pay between $200 and $700 per infusion when public hospital services cannot accommodate them promptly. General practitioner Dr. Rebekah Hoffman reported that roughly 90 percent of her infusion patients are women managing heavy menstrual bleeding.

The Royal Australian College of General Practitioners has lobbied for a $200 Medicare rebate. Federal Health Minister Mark Butler has referred the question to the Medical Services Advisory Committee. In the absence of subsidy, cost becomes another filter that disproportionately affects women already navigating dismissive clinical encounters.

Experts including Clarke, Hamad, and Uppal contributed to an unendorsed consensus statement recommending ferritin testing in early pregnancy and again at 24 to 28 weeks, with infusions offered when oral iron fails or cannot be tolerated. Without consistent implementation and funding, the statement remains guidance rather than standard practice.

The pattern across these accounts reveals how medical misogyny operates through laboratory standards, symptom normalization, and uneven access to treatment. Women such as Rodwell and Burns reached critical haemoglobin levels only after repeated dismissal. Updated reference ranges and expanded screening represent measurable steps already underway in some systems, yet the persistence of lower thresholds in parts of Australia and the United States, combined with the absence of routine ferritin testing outside pregnancy, continues to leave large numbers of women undiagnosed until their health reaches emergency thresholds.

Share via: